4.8 Article

Magnetic Bead-Based Reverse Colorimetric Immunoassay Strategy for Sensing Biomolecules

Journal

ANALYTICAL CHEMISTRY
Volume 85, Issue 14, Pages 6945-6952

Publisher

AMER CHEMICAL SOC
DOI: 10.1021/ac401433p

Keywords

-

Funding

  1. National 973 Basic Research Program of China [2010CB732403]
  2. National Natural Science Foundation of China [41176079, 21075019]
  3. Doctoral Program of Higher Education of China [20103514120003]
  4. National Science Foundation of Fujian Province [2011J06003]
  5. China-Russia Bilateral Scientific Cooperation Research Program (NSFC/RFBR) [21211120157]
  6. Program for Changjiang Scholars and Innovative Research Team in University [IRT1116]

Ask authors/readers for more resources

A novel reverse colorimetric immunoassay (RCIA) strategy was for the first time designed and utilized for sensitive detection of low-abundance protein (prostate-specific antigen, PSA, used in this case) in biological fluids by coupling highly catalytic efficient catalase with magnetic bead-based peroxidase mimics. To construct such a RCIA system, two nanostructures including magnetic beads and gold nanoparticles were first synthesized and functionalized with anti-PSA capture antibody and catalase/anti-PSA detection antibody, respectively. Thereafter, a specific sandwich-type immunoassay format was employed for determination of PSA by using functional gold nanopartides as enzymatic bioreactors and anti-PSA-conjugated magnetic beads as a calorimetric developer. The carried catalase, followed by the sandwiched immunocomplex, partially consumed the added hydrogen peroxide in the detection solution, which slowed down the catalytic efficiency of magnetic bead-based peroxidase mimics toward TMB/H2O2, thereby weakening the visible color and decreasing the colorimetric density. Different from conventional calorimetric immunoassay, the RCIA method determined the residual hydrogen peroxide in the substrate after consumption. Under the optimal conditions, the developed RC1A exhibited a wide dynamic range of 0.05-20 ng mL(-1) toward PSA with a detection limit of 0.03 ng mL(-1) at the 3S(blank) level. Infra- and interassay coefficients of variation were below 6.1% and 9.3%, respectively. Additionally, the methodology was further validated for the analysis of 12 PSA clinical serum specimens, giving results in good accordance with those obtained by the commercially available enzyme-linked immunosorbent assay (ELISA) method.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available